首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer research

缩写:CANCER RES

ISSN:0008-5472

e-ISSN:1538-7445

IF/分区:22.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引12921条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jiayan Zhu,Feng Wang,Lining Wang et al. Jiayan Zhu et al.
Peripheral T cell lymphoma (PTCL) is a heterogeneous and aggressive disease with a poor prognosis. Histone deacetylase (HDAC) inhibitors have shown inhibitory effects on PTCL. A better understanding of the therapeutic mechanism underlying t...
Wenzhi He,Min Wang,Xuechun Zhang et al. Wenzhi He et al.
Hepatocellular carcinoma (HCC) is an aggressive disease that occurs predominantly in men. Estrogen elicits protective effects against HCC development. Elucidation of the estrogen-regulated biological processes that suppress HCC could lead t...
Dandan Liu,Benliang Wei,Long Liang et al. Dandan Liu et al.
Circadian clock perturbation frequently occurs in cancer and facilitates tumor progression by regulating malignant growth and shaping the immune microenvironment. Emerging evidence has indicated that clock genes are disrupted in melanoma an...
Jonathan H Sussman,Nathalia Kim,Samantha B Kemp et al. Jonathan H Sussman et al.
Oncogenesis and progression of pancreatic ductal adenocarcinoma (PDAC) are driven by complex interactions between the neoplastic component and the tumor microenvironment, which includes immune, stromal, and parenchymal cells. In particular,...
Kevin MacPherson-Hawthorne,Rosalie C Sears Kevin MacPherson-Hawthorne
MYC is an oncogenic transcription factor that binds gene promoters to facilitate oncogenic gene expression. When overexpressed, as is the case in most human cancers, MYC also invades active enhancers-cis-regulatory elements that are critica...
Jie Xia,Lixing Zhang,Xilei Peng et al. Jie Xia et al.
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. IL1 receptor type 2 (IL1R2) promotes breast tumor-initiating cell (BTIC) self-renewal and tumor growth in TNBC, indicating that...
Ewa Sicinska,Vijaya S R Kola,Joseph A Kerfoot et al. Ewa Sicinska et al.
Alveolar soft part sarcoma (ASPS) is a rare mesenchymal malignancy driven by the ASPSCR1::TFE3 fusion. A better understanding of the mechanisms by which this oncogenic transcriptional regulator drives cancer growth is needed to help identif...
Sheng Yang,Dongsheng Zhang,Qingyang Sun et al. Sheng Yang et al.
Colorectal cancer (CRC) is one of the most common malignant tumors in humans, with liver metastasis being the primary cause of mortality. The epithelial-mesenchymal transition (EMT) process endows cancer cells with enhanced metastatic poten...
Raj K Shrestha,Zeyad D Nassar,Adrienne R Hanson et al. Raj K Shrestha et al.
Solid tumors are highly reliant on lipids for energy, growth, and survival. In prostate cancer, the activity of the androgen receptor (AR) is associated with reprogramming of lipid metabolic processes. Here, we identified acyl-CoA synthetas...